Successful Desensitization to Daratumumab After a Severe Life-threatening Reaction in a Patient With Refractory Multiple Myeloma

被引：2
|
作者：
Carron-Herrero, A. [1 ]
Solano-Solares, E. [1 ]
Rita, C. Geraldine [2 ]
Rodriguez-Martin, E. [2 ]
Ruedas, A. [3 ]
Barbolla, I. [3 ]
Berges-Gimeno, MP. [1 ,4 ]
机构：
[1] Hosp Univ Ramon y Cajal, Dept Allergol, IRYCIS, Madrid, Spain
[2] Hosp Univ Ramon y Cajal, Immunol Dept, IRYCIS, Madrid, Spain
[3] Hosp Univ Ramon y Cajal, Internal Med Dept, IRYCIS, Madrid, Spain
[4] ARADyAL, Spanish Themat Network & Cooperat Res Ctr, Madrid, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2021年 / 31卷 / 06期
关键词：
Daratumumab; Anaphylaxis; Desensitization; Multiple myeloma; Monoclonal antibody;
D O I：
10.18176/jiaci.0678
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：511 / 513
页数：3
相关论文
共 50 条
  • [1] Successful use of split-dose intravenous daratumumab in a multiple myeloma patient after a first-dose life-threatening infusion-related reaction
    Aykas, Fatma
    Karakus, Volkan
    Sevindik, Omur Gokmen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (02) : 397 - 399
  • [2] Desensitization to Lenograstim After a Life-threatening Reaction to Filgrastim
    Nunez-Acevedo, B.
    Rodriguez-Jimenez, B.
    Dominguez-Ortega, P.
    Gonzalez-Montellano, E.
    Ibanez-Heras, N.
    Enrech-Frances, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2015, 25 (02) : 158 - 160
  • [3] Successful use of split dose intravenous daratumumab in an overweight multiple myeloma patient after first dose life threatening infusion-related reaction
    Aykas, Fatma
    Karakus, Volkan
    Sevindik, Omur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S48 - S49
  • [4] Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma
    Ghasoub, Rola
    Benkhadra, Maria
    Kassem, Nancy
    Alshurafa, Awni
    Elsabah, Hesham
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) : 2041 - 2044
  • [5] Life-threatening asthma reaction caused by desensitization to milk
    Nieto, A.
    Fernandez-Silveira, L.
    Mazon, A.
    Caballero, L.
    ALLERGY, 2010, 65 (10) : 1342 - 1343
  • [6] Successful desensitization to nivolumab after a refractory severe cytokine release reaction
    De las Vecillas, L.
    Gutierrez, A.
    Montenegro, E.
    Lopez, J.
    Morchon, E.
    Rodriguez, F.
    King, K.
    Sanchez, L.
    Duran, I
    Pena, C.
    Caso, V
    Castanedo, P.
    ALLERGY, 2021, 76 : 262 - 262
  • [7] Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis
    Gorriz, M. C. Torres
    Cuartero, J. Borras
    Mendez, C. G. Pesantez
    Coronado, C. I. Stein
    Enrique, E.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (03) : 216 - 217
  • [8] LIFE-THREATENING REACTION TO GLUCAGON IN A PATIENT WITH PHEOCHROMOCYTOMA
    MCLOUGHLIN, MJ
    LANGER, B
    WILSON, DR
    RADIOLOGY, 1981, 140 (03) : 841 - 842
  • [9] Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization
    H Kook
    KM Kim
    SH Choi
    BS Choi
    HJ Kim
    SY Chung
    SJN Choi
    TJ Hwang
    Bone Marrow Transplantation, 1998, 21 : 727 - 729
  • [10] Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization
    Kook, H
    Kim, KM
    Choi, SH
    Choi, BS
    Kim, HJ
    Chung, SY
    Choi, SJN
    Hwang, TJ
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 727 - 729
12345